Nakamura, T. et al. 2024. Initial dose of tapentadol and concomitant use of duloxetine are associated with delirium occurring after initiation of tapentadol therapy in cancer patients. Journal of Opioid Management. 20, 6 (Dec. 2024), 495–502. DOI:https://doi.org/10.5055/jom.0859.